Cyclopropanemethanamine → N-tert-Butyl-2-((4-(4-(3-(cyclopropylmethyl)ureido)-3-fluorobenzoyl)piperazin-1-yl)methyl)thiazole-4-carboxamide
Reaction equation
[NH2:1][C:2]1[CH:28]=[CH:27][C:5]([C:6]([N:8]2[CH2:13][CH2:12][N:11]([CH2:14][C:15]3[S:16][CH:17]=[C:18]([C:20]([NH:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[N:19]=3)[CH2:10][CH2:9]2)=[O:7])=[CH:4][C:3]=1[F:29].Cl[C:31](OC1C=CC([N+]([O-])=O)=CC=1)=[O:32].[CH:43]1([CH2:46][NH2:47])[CH2:45][CH2:44]1>ClCCl.O>[C:23]([NH:22][C:20]([C:18]1[N:19]=[C:15]([CH2:14][N:11]2[CH2:12][CH2:13][N:8]([C:6](=[O:7])[C:5]3[CH:27]=[CH:28][C:2]([NH:1][C:31]([NH:47][CH2:46][CH:43]4[CH2:45][CH2:44]4)=[O:32])=[C:3]([F:29])[CH:4]=3)[CH2:9][CH2:10]2)[S:16][CH:17]=1)=[O:21])([CH3:26])([CH3:24])[CH3:25]Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
2-((4-(4-Amino-3-fluorobenzoyl)piperazin-1-yl)methyl)-N-tert-butylthiazole-4-carboxamide (100 mg, 0.238 mmol) and 4-nitrophenol chloroformate (48 mg, 0.238 mmol) were combined and stirred in dichloromethane for 1 hour at room temperature. Cyclopropylmethylamine (50.9 mg, 0.715 mmol, 62 μl) was added and the reaction was stirred for 30 minutes. The reaction mixture was diluted with water and flushed through a hydrophobic frit. The organic phase was concentrated under vacuum and purified by acidic reverse phase HPLC to afford the title compound (5 mg). MS (ESI) m/z 517.3 [M+H]+
Workup
- customflushed through a hydrophobic frit
- concentrationThe organic phase was concentrated under vacuum
- custompurified by acidic reverse phase HPLC
Sources & evidence
- ORD record
- ord-8995b7b89ce04f6887902198d245c9c1
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08759352B2
Reaction notes
Loading…